Introduction
renal osteodystrophy [10] . The group included 15 males (65%) and eight females (35%), with a mean age It has long been recognized that phosphorus retention of 51.1±12.6 years (mean±standard deviation) and and low concentrations of calcitriol are the two major creatinine clearance of 20.8±13.3 ml/min/1.73 m2. The pathogenetic mechanisms responsible for the develop-undecalcified bone biopsy showed three patients with ment of secondary hyperparathyroidism in chronic hyperparathyroid bone disease (13%), eight with mixed renal failure [1] [2] [3] . Support for the major role of bone disease (34.8%), four with osteomalacia (OM; phosphorus retention has been provided by several 17.4%) and eight with ABD (34.8%). No stainable investigators who have found that a decrease in the aluminium or iron was detected at the bone surface. amount of phosphorus in the diet, in proportion to They had not taken any vitamin D or calcium supplethe decrease in the glomerular filtration rate, prevents ment, phosphate binders, anti-convulsants or corticos- [1] or ameliorates [4] secondary hyperparathyroidism.
teroids. When compared with the other histological In patients with moderate renal insufficiency, restricsubgroups, ABD patients showed a more preserved tion of dietary phosphorus increases the production of renal function (creatinine clearance=32.8±14 vs calcitriol and decreases the concentrations of para-14.4±7.5 ml/min/1.73 m2) and did not show any thyroid hormone (PTH ) [4] .
acidosis. Normal to low serum PTH has been found to be
Within the whole population, a serum phosphorus associated with low turnover bone disease, mainly adynamic bone disease (ABD), in uraemic patients concentration ∏3.5 mg/dl was predictive of ABD (P= [5] [6] [7] . Conversely, increased PTH (three to four times 0.001). In the low turnover group (OM plus ABD), the upper normal value) has been found in patients serum total calcium was 9.2±1.6 mg/dl, and a signiwith normal bone [7] . This suggests that PTH overpro-ficant positive correlation was observed between serum duction is necessary to overcome the hormonal bone phosphorus and amino-terminal PTH (n=12; r=0.68; resistance that occurs in renal failure [8] . Moreover, P<0.05). Furthermore, in ABD patients, serum total normal or even low PTH found at times in uraemic calcium was normal (9.9±1.1 mg/dl ), and the lowest patients may lead to a low bone activity [6 ] . The serum phosphorus (3.1±0.9 mg/dl ) was associated causes of this 'relative hypoparathyroidism' [9], how-with the lower PTH, 10.3±3.3 pmol/l (normal values: ever, have not been established. Therefore, a question 14-27 pmol/l ), clearly indicating a relative hypoparacould be posed as to whether a low phosphorus intake, thyroidism. On the other hand, OM patients showed which is capable of preventing an increase in PTH, greater serum PTH (44.5±13.3 pmol/l ) and phoscould also induce hypoparathyroidism in uraemic phorus (5.0±1.5 mg/dl ) and a more deteriorated renal patients.
function (creatinine clearance=10.8±2.0 ml/min/ The answer of the above question may derive, at 1.73 m2). These results suggest that a low serum phosleast in part, from the nutritional, biochemical and phorus could be responsible for the low PTH observed bone biopsy studies we have conducted in our pre-in ABD patients. This assumption was reinforced by dialysis population.
the fact that our pre-dialysis patients had a low phosphorus intake (651±315 mg/day; n=17). Overt mal- showed normal body mass index (23±3 kg/m2).
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The mechanisms by which low phosphorus intake and/or low serum phosphorus could induce hypoparathyroidism are not clear. Some possibilities could be considered: (i) less physicochemical interaction with serum calcium [11]; (ii) less direct stimulation of the parathyroid gland by the phosphorus itself [12] ; and (iii) blocking of the parathyroid gland due to increased calcitriol resulting from a lesser action of phosphorus on 1-a hydroxylase activity [4, 13] . As serum calcium was normal, it is difficult to implicate hypercalcaemia as a cause of the low PTH. On the other hand, the third mechanism might be operating in our patients with low bone turnover, since in this group a significant negative correlation between serum calcitriol and PTH was found (Figure 1) . Furthermore, calcitriol concentrations in ABD patients, although not significant, were Fig. 2 . Relationship between serum phosphorus and intact parathormone (iPTH ) in 21 pre-dialysis patients with low bone mineral greater than those observed in the other patients density and histological diagnosis of adynamic bone disease.
(48.1±37.3 vs 26.7±14.4 pg/ml ). It has been shown that administration of vitamin D to pre-dialysis patients 1.9-6.2 mg/dl ) and intact PTH was 76 pg/ml was capable of inducing ABD [9] . In this study, serum (6-409 pg/ml ). Some patients showed serum phoscalcitriol concentrations were high and PTH was within phorus and PTH somewhat greater than those the normal range, i.e. not as high as could be expected observed in our first study. These results are in agreein the uraemic condition, suggesting a relative hypoparament with those of Hernandez et al.
[16 ] who found a thyroidism. Our ABD patients, on the contrary, were high prevalence of ABD with low PTH in uraemic prenot given vitamin D supplements. Since these patients dialysis patients. However, in their study, mean serum live in a sunny country, a high exposure to sunlight, phosphorus was greater than ours, perhaps due to a combined with a less deteriorated renal function and a more deteriorated renal function. Coen et al. [17] have low phosphorus intake, may have played a role in stressed the possibility that pre-dialysis patients may determining the greater calcitriol levels observed [4, 14] .
change their histological pattern of bone disease. If we However, a direct action of calcitriol on the parathyroid consider that better preserved renal function and low gland of ABD patients has to be proven. serum phosphorus favour the occurrence and are In another group of pre-dialysis patients, now markers of ABD, the findings of more decreased renal selected for showing low bone mineral density (median function and high serum phosphorus could be indicatof L 2 L 4 T-score=−2.63), a high prevalence of low ive of histological changes. Yet, in our two studies, turnover bone disease was also found (n=38; 95%).
OM patients showed a more severe renal failure comThey were 40 patients (25 males and 13 females), with bined with both higher phosphorus and PTH [15] . A a median age of 52.5 years and creatinine clearance of strong association between osteopenia and low turn-26.5 ml/min/1.73 m2 [15] . Again, ABD patients (n= over bone disease was observed in those pre-dialysis 21) showed a significant positive correlation between patients. In fact, as for ABD, this was the first time serum phosphorus and intact PTH (normal values:
we found patients with such diagnosis associated with 15-65 pg/ml; Figure 2 ). In the ABD subgroup, the a clear sign of bone disease, as is osteopenia, quantified median of serum phosphorus was 3.6 mg/dl (range= by dual photon bone absorptiometry.
An attempt to reverse hypoparathyroidism with phosphorus supplementation
More recently, in order to verify if we could reverse the hypoparathyroidism observed in low turnover bone disease, we have provided an oral phosphorus supplement (neutral complex phosphate) to 18 pre-dialysis patients with normal/low serum phosphorus and low PTH, or with ABD diagnosed through bone biopsy [18] . As can be seen in Table 1 , patients were given phosphorus for two consecutive months, in daily dosages of 0.5 g during the first month and 1.0 g during the second month. Throughout that period, serum creatinine did not change, suggesting maintenance of 
